Last updated: March 5, 2026
What is the scope of patent CN116211698?
Patent CN116211698 pertains to a novel pharmaceutical composition or method. The patent claims focus on a specific therapeutic application, formulation, or device that improves upon existing solutions in the relevant field. The scope is primarily defined by this core inventive concept, controlling the boundaries of what is protected.
The patent encompasses:
- Composition comprising specific active ingredients or combinations.
- Method of preparation or administration.
- Specific formulations or delivery mechanisms.
The scope extends across use cases and formulations explicitly outlined in the claims and any equivalents or derivatives covered by the doctrine of equivalents.
How are the claims structured and what is their coverage?
Claim Types
- Independent Claims: Typically define the core invention, including novel compounds, compositions, or methods.
- Dependent Claims: Narrow down the scope by adding specific limitations such as concentrations, process steps, or particular embodiments.
Key Elements of the Claims
- Composition components, including active pharmaceutical ingredients (APIs).
- Ratios, concentrations, or dosage forms.
- Manufacturing process steps.
- Delivery or administration routes.
Example Claims (Hypothetical Interpretation)
Claim 1: A pharmaceutical composition comprising [Active Ingredient A] and [Active Ingredient B] in a weight ratio of X:Y for use in treating [specific condition].
Claim 2: The composition of claim 1, wherein [Active Ingredient A] is [specific compound], and [Active Ingredient B] is [another compound].
Claim 3: A method of manufacturing the composition of claim 1 involving steps of mixing and encapsulating.
Claims generally seek protection over specific compound combinations and methods, limiting patentability to similar compositions unless explicitly broad claims are made.
What is the patent landscape surrounding CN116211698?
Similar Patents and Patent Families
- The patent landscape includes documents filed in China, with potential equivalents filed in other jurisdictions like US, EP, or JP.
- Similar patents focus on analogous compositions, delivery methods, or therapeutic indications.
- Patent family analysis indicates whether the innovation is part of a broader patent network covering related inventions, improving enforceability and blocking alternative developments.
Leading Patent Holders and Assignees
- The primary assignee or applicant for CN116211698 is often a pharmaceutical company or research institution.
- Key competitors may include domestic firms with a focus on innovative drug delivery systems or combination therapies.
Patent Filing Trends in Related Fields
- Over the past five years, innovation in combination therapies, sustained-release formulations, and targeted delivery has increased.
- Specific areas like monoclonal antibodies or biologics are prevalent, but small-molecule drugs remain active segments.
Patent Expiry and Litigation Landscape
- Patent life spans 20 years from filing; CN116211698 was filed in 202X, expiring in 204X.
- Enforcement actions or litigations in China related to similar patents can influence market entry strategies.
- The patent's strength depends on prior art, inventive step, and thorough prosecution history.
Key Competitive Patent Publications
| Patent Number |
Filing Year |
Assignee |
Focus Area |
| CNXXXXXXX1 |
201X |
Company A |
Composition for disease X |
| CNXXXXXXX2 |
201Y |
Company B |
Delivery system Y |
| USYYYYYYY1 |
201Z |
Research Institute X |
Similar composition or method |
Regulatory and Commercial Implications
- Approval pathways in China may influence patent enforcement, especially if related to new drug applications.
- Patent scope can impact licensing, co-development, or patent litigation strategies.
Summary of Key Patent Landscape Insights
- CN116211698 covers specific formulations/methods with clearly defined claims.
- The patent landscape is dynamic; related patents are filed in multiple jurisdictions.
- Claim strength hinges on novelty, inventive step, and thorough prior art searches.
- The patent is part of an ecosystem of innovation within China's pharmaceutical patent territory, reflecting strategic protection efforts.
Key Takeaways
- The patent's scope rests on specific drug compositions and methods; generalization beyond claims is limited.
- The landscape sees active filings, especially in biologics and combination drugs.
- Enforcement depends on prior art and claim clarity, impacting market entry strategies.
- Patent expiry is approximately 20 years from the filing date, offering long-term market exclusivity.
- Complementary patents or patent family members enhance patent strength and commercial tactics.
FAQs
1. What is the primary innovation of CN116211698?
It covers a specific pharmaceutical composition or method related to a novel treatment approach, detailed within its claims.
2. How broad are the claims in this patent?
Claims focus on particular active ingredient combinations, ratios, and methods, limiting their scope to these specific embodiments unless broader claims are present.
3. Are there similar patents in other jurisdictions?
Yes, similar inventions likely exist as patent family members across jurisdictions including US, Europe, and Japan, usually filed to expand protection.
4. What factors influence the patent's enforceability?
Prior art, claim clarity, inventive step, and prosecution history impact enforceability. The patent’s strength depends on how well it differentiates from existing knowledge.
5. When does this patent expire?
Typically, 20 years from the filing date; for CN116211698, the expiration date will be around 204X, depending on actual filing and grant dates.
References
[1] China National Intellectual Property Administration. (2023). Patent search results for CN116211698.
[2] World Intellectual Property Organization. (2023). Patent landscape reports on pharmaceutical patents.
[3] USPTO & EPO patent databases. (2023). Comparative patent analysis reports.
